Alpha Star Capital Management, LLC Bristol Myers Squibb CO Transaction History

Alpha Star Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$48.48 - $57.85 $413,243 - $493,113	8,524 New	8,524 $437,000
Q4 2022 Feb 08, 2023	SELL	$68.48 - $81.09 $18,968 - $22,461	-277 Reduced 4.17%	6,372 $458,000
Q3 2022 Oct 21, 2022	BUY	$0.13 - $76.84 $73 - $43,414	565 Added 9.29%	6,649 $473,000
Q2 2022 Jul 27, 2022	SELL	$72.62 - $79.98 $156,496 - $172,356	-2,155 Reduced 26.16%	6,084 $468,000
Q1 2022 Apr 28, 2022	BUY	$61.48 - $73.72 $113,860 - $136,529	1,852 Added 29.0%	8,239 $602,000
Q4 2021 Feb 04, 2022	SELL	$53.63 - $62.52 $134,557 - $156,862	-2,509 Reduced 28.2%	6,387 $415,000
Q3 2021 Nov 02, 2021	BUY	$59.17 - $69.31 $526,376 - $616,581	8,896 New	8,896 $514,000
Q1 2020 May 05, 2020	SELL	$46.4 - $67.43 $488,452 - $709,835	-10,527 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$49.21 - $64.19 $89,906 - $117,275	1,827 Added 21.0%	10,527 $676,000
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $42,727 - $50,659	999 Added 12.97%	8,700 $441,000
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $343,618 - $379,967	7,701 New	7,701 $349,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Alpha Star Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Star Capital Management, LLC with notifications on news.